HekaBio Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
21
- Latest Deal Type
-
Series B
- (In Progress)
- Latest Deal Amount
-
$20M
- Investors
-
6
HekaBio General Information
Description
Operator of an asset-light healthcare platform intended to offer radiation and other therapies for oncology and fibrotic disease and to invest in global healthcare technology. The company offers a broad category of development expertise in pharma, medical devices, in-vitro diagnostics, digital health, and cell and gene therapies, enabling researchers to advance a portfolio of breakthrough programs and provide patients with accelerated access to global healthcare innovations.
Contact Information
Website
www.heka.bioCorporate Office
- Chikiriya Tokyo Building, 8th Floor
- 1-9-15 Nihonbashi Muromachi Chuo-ku
- Tokyo, 103-0022
- Japan
Corporate Office
- Chikiriya Tokyo Building, 8th Floor
- 1-9-15 Nihonbashi Muromachi Chuo-ku
- Tokyo, 103-0022
- Japan
HekaBio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC (Series B) | 10-Jul-2026 | $20M | In Progress | Generating Revenue | ||
| 8. Later Stage VC | 16-Jun-2025 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series B) | 29-Jan-2021 | Completed | Generating Revenue | |||
| 6. Early Stage VC (Series A) | 23-Sep-2020 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series A3) | 31-Mar-2020 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A2) | 31-Jul-2019 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A1) | 07-Dec-2018 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 30-Apr-2018 | $3.01M | $11M | Completed | Generating Revenue | |
| 1. Seed Round | 01-Jan-2018 | $8M | $8M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
HekaBio Comparisons
Industry
Financing
Details
HekaBio Competitors (10)
One of HekaBio’s 10 competitors is Roche, a Corporation company based in Basel, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Roche | Corporation | Basel, Switzerland | ||||
| Becton, Dickinson and Company | Corporation | Franklin Lakes, NJ | ||||
| Siemens Healthineers | Corporation | Forchheim, Germany | ||||
| Cepheid | Formerly VC-backed | Sunnyvale, CA | ||||
| Agilent Technologies | Formerly PE-Backed | Santa Clara, CA |
HekaBio Signals
HekaBio Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alfresa Holdings | Corporation | Minority | ||
| Cosmo Public Relations | Corporation | Minority | ||
| Essential Pharma (Tokyo) | Corporation | Minority | ||
| Medifuture | Corporation | Minority | ||
| Ohara Pharmaceutical | VC-Backed Company | Minority |
HekaBio Investments & Acquisitions (6)
HekaBio’s most recent deal was a Later Stage VC with Vista (Decision/Risk Analysis) for . The deal was made on 01-Jul-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Vista (Decision/Risk Analysis) | 01-Jul-2023 | Later Stage VC | Decision/Risk Analysis | ||
| Limaca Medical | 02-Jan-2023 | Later Stage VC | Diagnostic Equipment | ||
| AllMeD Solutions | 01-Dec-2022 | PIPE | Therapeutic Devices | ||
| SalutarisMD | 01-May-2021 | Later Stage VC | Surgical Devices | ||
| Alpha Tau Medical | 13-Mar-2020 | Early Stage VC | Drug Discovery |
HekaBio FAQs
-
When was HekaBio founded?
HekaBio was founded in 2016.
-
Where is HekaBio headquartered?
HekaBio is headquartered in Tokyo, Japan.
-
What is the size of HekaBio?
HekaBio has 21 total employees.
-
What industry is HekaBio in?
HekaBio’s primary industry is Biotechnology.
-
Is HekaBio a private or public company?
HekaBio is a Private company.
-
What is HekaBio’s current revenue?
The current revenue for HekaBio is .
-
How much funding has HekaBio raised over time?
HekaBio has raised $23.7M.
-
Who are HekaBio’s investors?
Alfresa Holdings, Cosmo Public Relations, Essential Pharma (Tokyo), Medifuture, and Ohara Pharmaceutical are 5 of 6 investors who have invested in HekaBio.
-
Who are HekaBio’s competitors?
Roche, Becton, Dickinson and Company, Siemens Healthineers, Cepheid, and Agilent Technologies are some of the 10 competitors of HekaBio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process